FilingSEC EDGAR8-K
Silexion Therapeutics Announces Warrant Exercise Price Reduction and New Warrant Issuance
· SEC accepted
StageAgreement Signed
Filing content
The company agreed to reduce the exercise price of existing warrants to $0.2603 and issue 6,433,856 new warrants in exchange for the cash exercise of existing warrants.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…